“bridgebio-pharma” Archives

in
Entry Author Date Location
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia 08/12/20 San Francisco
Diversity & Inclusion Events Have Halted. Our Conversations Shouldn’t. 06/22/20 Boston
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline 06/04/20 Boston
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
BridgeBio’s Pipeline Expansion Continues as Portfolio’s Milestones Approach 04/30/20 San Francisco
Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown 03/23/20 National
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
BridgeBio Pharma Hauls in $299M for Genetic Disease Drugs R&D 01/23/19 San Francisco
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours 06/21/18 National
Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates 06/15/18 National
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
Cullinan Oncology Emerges with $150M to Build Cancer Drug Portfolio 10/03/17 Boston
Bio Roundup: Phase 3 Fails, Shkreli Jailed, Moderna Flip-Flops & More 09/15/17 National
Xconomy Award Finalists in the Eye of the National Drug Price Debate 09/13/17 Boston
Bio Roundup: Trumpcare Flails, Spinraza Sales, Batten OK & More 04/28/17 National
Page 1 of 1